CSL Limited
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. Show More...
-
Website http://www.csl.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 138.80 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share AUD 1.85 1.73 1.89 2.62 2.86 3.81 3.61 3.81 5.15 6.02 6.32 Dividends AUD 0.68 0.81 0.96 1.16 1.39 2.06 1.72 1.92 2.48 2.66 Payout Ratio % * 39.2 45.8 38.3 36.4 39.3 39.6 52.1 39.5 40.0 42.0 Shares Mil 569.0 542.0 520.0 500.0 486.0 472.0 463.0 456.0 454.0 454.0 454.0 Book Value Per Share * EUR 5.35 5.13 5.75 4.94 5.35 5.38 5.73 5.95 6.92 9.34 11.44 Free Cash Flow Per Share * EUR 1.07 1.1 1.31 1.25 1.23 1.76 1.86 0.94 0.81 0.94 Return on Assets % 16.1 17.45 18.05 21.39 21.17 23.94 18.07 15.77 17.7 17.03 15.77 Financial Leverage (Average) 1.35 1.39 1.7 1.99 1.99 2.33 2.95 2.88 2.64 2.35 2.35 Return on Equity % 21.76 23.94 27.79 39.32 42.05 51.8 47.57 45.94 48.57 42.07 36.94 Return on Invested Capital % 19.08 21.28 22.4 27.23 27.19 30.93 24.38 21.45 23.54 22.87 20.16 Interest Coverage 76.97 83.74 32.12 31.76 31.27 29.76 22.73 19.78 22.04 14.25 16.72 Current Ratio 4.24 2.92 3.62 3.6 3.79 3.57 2.78 2.84 2.61 2.53 2.53 Quick Ratio 2.36 1.35 2.03 1.74 1.8 1.62 1.16 1.21 1.14 1.08 1.08 Debt/Equity 0.1 0.05 0.32 0.56 0.59 0.83 1.2 1.22 1.02 0.81 0.81